Literature DB >> 10036316

Maroteaux-lamy syndrome: five novel mutations and their structural localization.

G R Villani1, N Balzano, D Vitale, M Saviano, V Pavone, P Di Natale.   

Abstract

Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI, MPS VI) is an autosomal recessive disorder due to the deficiency of the lysosomal enzyme N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ASB). Mutation analysis in Maroteaux-Lamy syndrome resulted in the identification of approximately 40 molecular defects underlying a great genetic heterogeneity. Here we report five novel mutations in Italian subjects: S65F, P116H, R315Q, Q503X, P531R; each defect was confirmed by restriction enzyme or amplification refractory mutation system (ARMS) analysis. We also performed a three-dimensional (3-D) structure analysis of the alterations identified by us, and of an additional 22 point mutations reported by other groups, in an attempt to draw helpful information about their possible effects on protein conformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10036316     DOI: 10.1016/s0925-4439(98)00099-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.

Authors:  M F G Petry; K Nonemacher; J C Sebben; I V D Schwartz; A C M Azevedo; M G Burin; A R de Rezende; C A Kim; R Giugliani; S Leistner-Segal
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

3.  Identification of eleven different mutations including six novel, in the arylsulfatase B gene in Iranian patients with mucopolysaccharidosis type VI.

Authors:  Rokhsareh Jafaryazdi; Sedigheh Shams; Anna Isaian; Aria Setoodeh; Shahram Teimourian
Journal:  Mol Biol Rep       Date:  2019-04-13       Impact factor: 2.316

4.  Segregation analysis in a family at risk for the Maroteaux-Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism.

Authors:  Alessandra Zanetti; Elena Ferraresi; Luigi Picci; Mirella Filocamo; Rossella Parini; Camillo Rosano; Rosella Tomanin; Maurizio Scarpa
Journal:  Eur J Hum Genet       Date:  2009-03-04       Impact factor: 4.246

5.  Molecular Analysis of Turkish Maroteaux-Lamy Patients and Identification of One Novel Mutation in the Arylsulfatase B (ARSB) Gene.

Authors:  Alessandra Zanetti; Neslihan Onenli-Mungan; Nursel Elcioglu; Mehmet Nuri Ozbek; Deniz Kör; Elisabetta Lenzini; Maurizio Scarpa; Rosella Tomanin
Journal:  JIMD Rep       Date:  2013-11-16

Review 6.  Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene.

Authors:  Rosella Tomanin; Litsa Karageorgos; Alessandra Zanetti; Moeenaldeen Al-Sayed; Mitch Bailey; Nicole Miller; Hitoshi Sakuraba; John J Hopwood
Journal:  Hum Mutat       Date:  2018-09-17       Impact factor: 4.878

7.  Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases.

Authors:  Marta Gómez-Grau; Elena Garrido; Mónica Cozar; Víctor Rodriguez-Sureda; Carmen Domínguez; Concepción Arenas; Richard A Gatti; Bru Cormand; Daniel Grinberg; Lluïsa Vilageliu
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

Review 8.  Diagnostic and treatment strategies in mucopolysaccharidosis VI.

Authors:  Filippo Vairo; Andressa Federhen; Guilherme Baldo; Mariluce Riegel; Maira Burin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Appl Clin Genet       Date:  2015-10-30

9.  Mutations in ARSB in MPS VI patients in India.

Authors:  Juby Mathew; Sujatha M Jagadeesh; Meenakshi Bhat; S Udhaya Kumar; Saravanamuthu Thiyagarajan; Sudha Srinivasan
Journal:  Mol Genet Metab Rep       Date:  2015-07-17

10.  Mucopolysaccharidosis VI in cats - clarification regarding genetic testing.

Authors:  Leslie A Lyons; Robert A Grahn; Francesca Genova; Michela Beccaglia; John J Hopwood; Maria Longeri
Journal:  BMC Vet Res       Date:  2016-07-02       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.